Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-08-08
2006-08-08
Weber, Jon (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S395000, C530S350000
Reexamination Certificate
active
07087721
ABSTRACT:
The present invention relates to compositions, kits and treating methods for the alteration cell-cell adhesion, transport, or permeation properties of tissues. The present invention also relates to the application of drug(s) or peptide(s), compound or gene delivery, DNA or RNA(i), cosmetic or therapeutic use of the compositions and kits.
REFERENCES:
patent: 5639625 (1997-06-01), Carson et al.
Huey-Chung Huang, et al., “Thrombomodulin-mediated Cell Adhesion”,The Journal of Biological Chemistry, vol. 278, No. 47, Issue of Nov. 21, pp. 46750-46759, 2003.
C. T. Esmon, et al., “Complex Formation between Thrombin and Thrombomodulin Inhibits Both Thrombin-catalyzed Fibrin Formation and Factor V Activation”,The Journal of Biological Chemistry, vol. 257, No. 14, Issue of Jul. 25, pp. 7944-7947, 1982.
C. T. Esmon, “Thrombomodulin as a Model of Molecular Mechanisms that Modulate Protease Specificity and Function at the Vessel Surface”,The FASEB Journal, 946, vol. 9, Jul. 1995.
M. C. Boffa, et al., “Preservation of Thrombomodulin Antigen on Vascular and Estravascular Surfaces”,The Journal of Histochemistry and Cytochemistry, vol. 35, No. 11, pp. 1267-1276, 1987.
A. M. Healy, et al., “Absence of the Blood-Clotting Regulator Thrombomodulin Causes Embryonic Lethality in Mice Before Development of a Functional Cardiovascular System”,Proc. Natl. Acad. Sci., USA, vol. 92, pp. 850-854, Jan. 1995.
T. J. Raise, et al, “Keratinocyte-Specific Expression of Human Thrombomodulin in Transgenic Mice: Effects of Epidermal Differentiation and Cataneous Wound Healing”,Journal of Investigative Medicine, vol. 46, No. 4, Apr. 1998.
D. A. Lane, et al., “Role of Hemostatic Gene Polymorphisms in Venous and Arterial Thrombotic Disease”,Blood, Mar. 1, 2000, vol. 95, No. 5, pp. 1517-1532.
Y. Tezuka et al., “Expression of Thrombomodulin in Esophageal Squamous Cell Carcinoma and Its Relationship to Lymph Node Metastasis”,Cancer Reseach, 55, 4196-4200, Sep. 15, 1995.
T. M. Sugihara, et al., “An Immunohistochemical Study of Thrombomodulin in Oral Squamous Cell Carcinoma and its Association with Invasive amd Metastatic Potential”,J. Oral Pathol Med, 1997: 26: 258-264.
T. Suehiro et al., “Thrombomodulin Inhibits Intrahepatic Spread in Human Heptocellular Carcinoma”,Hepatology, May 1995, pp. 1285-1290.
Youming Zhang, et al., “Thrombomodulin Modulates Growth of Tumor Cells Independent of its Anticoagulant Activity”,Thrombomodulin Modulates Tumor Growths, pp. 1301-1309.
K. Suzuki, et al., “Structure and Expression of Human Thrombomodulin, a Thrombin Receptor on Endothelium Acting as a Cofactor for Protein C Activation”,The EMBO Journal, vol. 6, No. 7, pp. 1891-1897, 1987.
T. E. Petersen, “The Amino-Terminal Domain of Thrombomodulin and Pancreatic Stone Protein are Homologous with Lectins”,FEB Letters, vol. 231, No. 1, pp. 51-53, Apr. 1988.
C. H. Chay, et al., “Evidence for Lectin Signaling to the Nuclear Matrix: Cellular Interpretation of the Glycocode”,Journal of Cellular Biochemistry Supplemental, 35:123-129 (2000).
R. Mody, et al., “Use of Lectins as Diagnostic and Therapeutic Tools for Cancer”,Journal of Pharmacological and Toxicological Methods, 33, pp. 1-10 (1995).
L. LaRue, et al., “E-Cadherin Null Mutant Embryos Fail to Form a Trophectoderm Epithelium”,Proc. Natl. Acad. Sci., vol. 91, pp. 8263-8267, Aug. 1994.
D. Tiethmacher, et al., “A Targeted Mutation in the Mouse E-Cadherin Gene Results in Defective Preimplantation Development”,Proc. Natl. Acad. Sci., vol. 92, pp. 855-859, Jan. 1995.
R. O. Hynes, et al., “Perspective Series: Cell Adhesion in Vascular Biology”Genetic Manipulation of Vascular Adhesion Molecules in Mice, pp. 2193-2195.
H. Ogawa, et al., “Expression of Thrombomodulin in Squamous Cell Carcinoma of the Lung: Its Relationship to Lymph Node Metastasis and Prognosis of the Patients”,Cancer Letters, 149 (2000) pp. 95-103.
T. J. Raife, et al., “Thrombomodulin Expression by Human Keratinocytes”,Keratinocyte Thrombomodulin, pp. 1846-1851.
Y. Matsushita, et al., “A Subcloned Human Esophageal Squamous Cell Carcinoma Cell Line with Low Thrombomodulin Expression Showed Increased Invasiveness Compared with a High Thrombomodulin-Expressing Clone—Thrombomodulin as a Possible Candidate for an Adhesion Molecule of Squamous Cell Carcinoma”,Cancer Letters, 127 (1998) pp. 195-201.
D. J. Lager et al., “Cellular Localization of Thrombomodulin in Human Epithelium and Squamous Malignancies”,American Journal of Pathology, vol. 146, No. 4, Apr. 1995.
M. Takeichi, “Cadherin Cell Adhesion Receptors as a Morphogenetic Regular”,Science, vol. 25, pp. 1451-1455, Mar. 22, 1991.
M. Conacci-Sorrell, et al., “The Cadherin-Catenin Adhesion System in Signaling and Cancer”,The Journal of Clinical Investigation, Apr. 1002, vol. 109, No. 8, pp. 987-991.
P. Boukamp, et al., “Normal Keratinization in a Spontaneously Immortalized Aneuploid Human Keratinocyte Cell Line”,The Journal of Cell Biology, vol. 106, 1988, pp. 761-771.
B. Herren, et al., “ADAM15 Overexpression in NIH3T3 Cells Enhances Cell-Cell Interactions”,Experimental Cell Research, 271, 152-160 (2001).
M. S. Kinch, et al., “Tyrosine Phosphorylation Regulates the Adhesions of Ras-Transformed Breast Epithelia”,The Journal of Cell Biology, vol. 130, 1995, pp. 461-471.
M. Pignatelli, et al., “Morphoregulatory Activities of E-Cadherin and beta-1 Integrins in Colorectal Tumor Cells”,Br. J. Cancer, (1992), 66, pp. 629-634.
H. Togashi, et al., “Cadherin Regulates Dendritic Spine Morphogenesis”,Neuron, vol. 35, pp. 77-89, Jul. 3, 2002.
E. M. Conway, et al., “The Amino Terminal Lectin-Like Domain of Thrombomodulin is Required for Constitutive Endocytosis”,Blood, vol. 89, No. 2, 1997, pp. 652-661.
E. M. Conway, et al., “The Lectin-Like Domain of Thrombomodulin Confers Protection from Neutrophil-Mediated Tissue Damage by Suppressing Adhesion Molecule Expression Via Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways”,J. Exp. Med., vol. 196, No. 5, Sep. 2, 2002, pp. 565-577.
S. Hirano, et al., “Calcium-Dependent Cell-Cell Adhesion Molecules (Cadherins): Subclass Specificities and Possible Involvement of Actin Bundles”,The Journal of Cell Biology, vol. 105 (No. 6, Pt. 1), Dec. 1987, pp. 2501-2510.
A. Hubbard, et al., “Intercellular Adhesion Molecule-1 (ICAM-1) Expression and Cell Signling Cascades”,Free Radical Biology&Medicine, vol. 28, No. 9, pp. 1379-1386, 2000.
S. D. Rosen, et al., “Ligands for L-Selectin: Homing, Inflammation, and Beyond”,Annu. Rev. Immunol. 2004, 22:129-156.
A. Varki, et al., “P-Selectin, Carcinoma Metastasis and Heparin: Novel Mechanistic Connections with Therapeutic Implications”,Brazilian Journal of Medical and Biological Research, 2001, 34: 711-717.
P. D. Stahl, “The Mannose Receptor and Other Macrophage Lectins”,Current Opinion in Immunology, 1992, 4:49-52.
K. Nawa, et al., “Presence and Function of Chondroitin-4-Sulfate on Recombinant Human Soluble Thrombomodulin”,Biochemical and Biophysical Research Communication, pp. 729-737.
L. Pollack et al., “Correlation of Glycosylation Forms with Position in Amino Acid Sequence”,The Journal of Cell Biology, vol. 97, Aug. 1983, 293-300.
S. Pokutta et al., “The Cytoplasmic Face of Cell Contact Sites”,Current Opinion in Structural Biology, 2002, 12:255-262.
E. M. Conway, et al. “Structure-Function Analyses of Thrombomodulin by Gene-Targeting in Mice: The Cytoplasmic Domain is not Required for Normal Fetal Development”,Blood, vol. 93, No. 10, May 15, 1999, pp. 3442-3450.
N. G. Ordónez, “Transitional Cell Carcinomas of the Ovary and Bladder
Huang Huey-Chun
Shi Guey-Yueh
Wu Hua-Lin
Cohen & Pontani, Lieberman & Pavane
Noakes Suzanne M.
Weber Jon
LandOfFree
Compositions, kits and treating methods for alteration... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions, kits and treating methods for alteration..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions, kits and treating methods for alteration... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3663477